Loading...
Stryker reported a strong second quarter in 2023, with net sales increasing by 11.2% to $5.0 billion and organic net sales increasing by 11.9%. The company is back on its margin expansion pathway and its supercycle of innovation is progressing well. Adjusted EPS increased 12.9% to $2.54.
Net sales increased by 11.2% to $5.0 billion.
Organic net sales increased by 11.9%.
Reported EPS increased 12.2% to $1.93.
Adjusted EPS increased 12.9% to $2.54.
Stryker expects full year 2023 organic net sales growth to be in the range of 9.5% to 10.5%, including slightly positive pricing for the year. Adjusted net earnings per diluted share are expected to be in the range of $10.25 to $10.45.